Hoffmann & Baron brings advanced scientific expertise in the pharmaceutical industry to secure and defend intellectual property (IP) for groundbreaking treatments and pharmaceutical innovations. Our team has extensive experience in developing IP portfolios, starting from the early stages of discovery and screening through to candidate identification, formulation, and testing. We ensure that each portfolio is aligned with the appropriate development phase and the necessary public disclosures related to testing.
Our expertise spans various IP strategies, including the repurposing of drugs, reformulation for patent term extension, and protection of a wide range of assets. These include small molecule therapeutics, biologics (particularly in oncology and immunology), and advanced drug delivery systems.
